Literature DB >> 328108

Effects of naloxone on pethidine-induced neonatal depression. Part I--Intravenous naloxone.

P C Wiener, M I Hogg, M Rosen.   

Abstract

Infants whose mothers had had pethidine during labour were given either naloxone 40 microgram or isotonic saline administered intravenously double-blind within one minute of birth. Peak alveolar carbon dioxide tension, carbon dioxide excretion, alveolar ventilation, feeding behaviour, and habituation to a specific sound stimulus were measured regularly up to 48 hours after birth. Alveolar carbon dioxide tension was significantly lower and alveolar ventilation significantly higher half an hour after birth in the naloxone-treated group than in the saline-treated group, but these differences between the groups were not significant at any other time, and there were no significant differences in sucking frequency or pressure, milk consumption, or habituation to the auditory stimulus.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 328108      PMCID: PMC1631408          DOI: 10.1136/bmj.2.6081.228

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  9 in total

1.  EFFECTS OF MEPERIDINE ON THE NEWBORN INFANT.

Authors:  S M SHNIDER; F MOYA
Journal:  Am J Obstet Gynecol       Date:  1964-08-15       Impact factor: 8.661

2.  Serial oxygen saturation studies of newborn infants following obstetrical complications, difficult deliveries, and cesarean section.

Authors:  L V SHIELDS; E S TAYLOR
Journal:  Am J Obstet Gynecol       Date:  1957-05       Impact factor: 8.661

3.  Measurement of carbon dioxide output, alveolar carbon dioxide concentration and alveolar ventilation in the neonate.

Authors:  J M Evans; M I Hogg; M Rosen
Journal:  Br J Anaesth       Date:  1977-05       Impact factor: 9.166

4.  Obstetric meperidine usage and assessment of neonatal status.

Authors:  Y Brackbill; J Kane; R L Manniello; D Abramson
Journal:  Anesthesiology       Date:  1974-02       Impact factor: 7.892

5.  The relation between laboratory measures of sucking, food intake, and perinatal factors during the newborn period.

Authors:  J Dubignon; D Campbell; M Curtis; M W Partington
Journal:  Child Dev       Date:  1969-12

6.  The effect of pethidine on the postnatal adjustment of respiration and acid base balance.

Authors:  G Koch; H Wendel
Journal:  Acta Obstet Gynecol Scand       Date:  1968       Impact factor: 3.636

7.  Newborn sucking behavior affected by obstetric sedation.

Authors:  R E Kron; M Stein; K E Goddard
Journal:  Pediatrics       Date:  1966-06       Impact factor: 7.124

8.  Degree and duration of reversal by naloxone of effects of morphine in conscious subjects.

Authors:  J M Evans; M I Hogg; J N Lunn; M Rosen
Journal:  Br Med J       Date:  1974-06-15

9.  Reversal of narcotic depression in the neonate by nalozone.

Authors:  J M Evans; M I Hogg; M Rosen
Journal:  Br Med J       Date:  1976-11-06
  9 in total
  9 in total

Review 1.  Drugs in pregnancy: effects on the fetus and newborn.

Authors:  R M Hill; L Stern
Journal:  Drugs       Date:  1979-03       Impact factor: 9.546

2.  Effects of naloxone on pethidine-induced neonatal depression.

Authors:  P C Wiener; S Wallace
Journal:  Br Med J       Date:  1980-01-26

Review 3.  Treatment options for the relief of pain during childbirth.

Authors:  P Brownridge
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

4.  Maternal kinetics and transplacental passage of pethidine during labour.

Authors:  G Tomson; R I Garle; B Thalme; H Nisell; L Nylund; A Rane
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

5.  Effects of pethidine and its antagonists on the newborn.

Authors:  J E Brice; T A Moreland; C H Walker
Journal:  Arch Dis Child       Date:  1979-05       Impact factor: 3.791

Review 6.  Naloxone for narcotic exposed newborn infants: systematic review.

Authors:  W McGuire; P W Fowlie
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-07       Impact factor: 5.747

7.  Naloxone pharmacokinetics in the newborn.

Authors:  T A Moreland; J E Brice; C H Walker; A C Parija
Journal:  Br J Clin Pharmacol       Date:  1980-06       Impact factor: 4.335

8.  Naloxone protein binding in adult and foetal plasma.

Authors:  L A Asali; K F Brown
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Naloxone for opioid-exposed newborn infants.

Authors:  Thirimon Moe-Byrne; Jennifer Valeska Elli Brown; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2018-10-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.